Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Statins significantly reduce testosterone and improve skin symptoms in women with PCOS.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

Finasteride showed limited hair growth and low patient compliance in treating male pattern baldness.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Most men stopped using finasteride for baldness due to unsatisfactory results or were lost to follow-up, and those who continued saw minimal to moderate improvement.

Photobiomodulation therapy significantly increases hair density and growth for androgenic alopecia, but more research is needed to confirm safety.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Oral and topical minoxidil are equally effective for hair loss, but oral minoxidil causes more unwanted hair growth.

The Scalp Coverage Scoring method reliably measures hair density from images.

Microneedle treatment combined with minoxidil significantly increases hair count for hair loss patients.

The document's conclusion cannot be provided because the content is not available.

5α-Reductase inhibitors can negatively impact sexual function.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

PRP is an effective and safe treatment for hair loss.